🇺🇸 Narcotic pain medication in United States

18 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chest Pain — 2 reports (11.11%)
  2. Decreased Appetite — 2 reports (11.11%)
  3. Drug Ineffective — 2 reports (11.11%)
  4. Lymph Gland Infection — 2 reports (11.11%)
  5. Migraine — 2 reports (11.11%)
  6. Pain — 2 reports (11.11%)
  7. Pulmonary Embolism — 2 reports (11.11%)
  8. Sinusitis — 2 reports (11.11%)
  9. Abdominal Pain Upper — 1 report (5.56%)
  10. Alopecia — 1 report (5.56%)

Source database →

Narcotic pain medication in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Narcotic pain medication approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Narcotic pain medication in United States?

Henry Ford Health System is the originator. The local marketing authorisation holder may differ — check the official source linked above.